Daxor Corporation (DXR) - Financial and Strategic SWOT Analysis Review

Date: August 5, 2014
Pages: 43
Price:
US$ 125.00
License [?]:
Publisher: GlobalData
Report type: Strategic Report
Delivery: E-mail Delivery (PDF)
ID: D1AF3A23671EN
Leaflet:

Download PDF Leaflet

Daxor Corporation (DXR) - Financial and Strategic SWOT Analysis Review
Daxor Corporation (DXR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:
  • Business description – A detailed description of the company’s operations and business divisions.
  • Corporate strategy – Analyst’s summarization of the company’s business strategy.
  • SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history – Progression of key events associated with the company.
  • Major products and services – A list of major products, services and brands of the company.
  • Key competitors – A list of key competitors to the company.
  • Key employees – A list of the key executives of the company.
  • Executive biographies – A brief summary of the executives’ employment history.
  • Key operational heads – A list of personnel heading key departments/functions.
  • Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
  • Key manufacturing facilities – A list of key manufacturing facilities of the company.
  • Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Highlights

Daxor Corporation (Daxor) is an investment company with medical instrumentation and biotechnology operations. Its flagship product, BVA-100 Blood Volume Analyzer is an instrument to measure human blood volume. It is used in conjunction with Volumex, a single-use radiopharmaceutical diagnostic injection and collection kit. The company also offers cryobanking services including semen banking, autologous blood banking services, andrology services and general clinical laboratory testing through its subsidiary Scientific Medical Systems Corp.’s IDANT Laboratories division.

Daxor Corporation Key Recent Developments

Jan 07, 2014: Classic Textbook on Critical Care, the ICU book by Paul Marino, M.D., PhD., Recommends Direct Measurement of Blood Volume in Evaluating Critically Ill Patients
Nov 15, 2013: Daxor Announces Payment of a Dividend
Aug 07, 2013: Daxor Corporation Announces Receipt of Blood Banking Contract From Prestigious Law Firm Stroock & Stroock & Lavan
Jul 11, 2013: Daxor Corporation Announces Publication of "Blood Volume Determination, A Nuclear Medicine Test in Evolution"
Feb 14, 2013: Reports Of Study Comparing Daxor’s Direct Blood Volume Measurement With Non-invasive Hemoglobin Monitor In Critically Ill Surgical Patients

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers. - The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company. - The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably. - Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance. - Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research. - Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company
SECTION 1 - ABOUT THE COMPANY

Daxor Corporation - Key Facts
Daxor Corporation - Key Employees
Daxor Corporation - Key Employee Biographies
Daxor Corporation - Major Products and Services
Daxor Corporation - Medical Equipment Pipeline Products Data
Daxor Corporation Pipeline Products by Equipment Type
Daxor Corporation Pipeline Products by Development Stage
Daxor Corporation - History
Daxor Corporation - Company Statement
Daxor Corporation - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries

SECTION 2 – COMPANY ANALYSIS

Daxor Corporation - Business Description
Daxor Corporation - SWOT Analysis
SWOT Analysis - Overview
Daxor Corporation - Strengths
Strength - Broad Service Offerings- Cryobanking Services
Strength - BVA-100 Blood Volume Analyzer
Daxor Corporation - Weaknesses
Weakness - Dependence on Limited Manufacturer Base
Weakness - Declining Profitability
Daxor Corporation - Opportunities
Opportunity - Growing Aged Population
Opportunity - Market Potential
Opportunity - Scientific Studies Employing BVA-100
Daxor Corporation - Threats
Threat - Cost Containment Pressures
Threat - Rapid Technological Changes
Threat - Stringent Government Regulations
Daxor Corporation - Key Competitors

SECTION 3 – COMPANY FINANCIAL RATIOS

Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts

SECTION 4 – COMPANY’S LIFESCIENCES FINANCIAL DEALS AND ALLIANCES

Daxor Corporation, Medical Equipment, Deals By Year, 2008 to YTD 2014
Daxor Corporation, Medical Equipment, Deals By Type, 2008 to YTD 2014
Daxor Corporation, Recent Deals Summary

SECTION 5 – COMPANY’S RECENT DEVELOPMENTS

Apr 30, 2014: Daxor's Idant Laboratories Subsidiary Earns American Association of Blood Banks (AABB) Accreditation Again
Jan 15, 2014: Daxor Announces a Research Study That Proves Micro Samples Are Feasible for Accurate Blood Volume Measurements on Infants and Small Children Utilizing the BVA-100 Blood Volume Analyzer
Nov 15, 2013: Daxor Announces Payment of a Dividend
Oct 25, 2013: Daxor Announces a Study on the Significant Diagnostic Benefits to Congestive Heart Failure Patients Utilizing the Daxor BVA-100 Blood Volume Analyzer
Oct 08, 2013: Daxor Corporation Announces Results of Blood Volume Measurement Study at the Mayo Clinic Presented at the 17th Annual American Heart Failure Society Meeting in Orlando, Florida
Aug 07, 2013: Daxor Corporation Announces Receipt of Blood Banking Contract From Prestigious Law Firm Stroock & Stroock & Lavan
Jul 11, 2013: Daxor Corporation Announces Publication of "Blood Volume Determination, A Nuclear Medicine Test in Evolution"
May 16, 2013: Daxor Corporation Announces Placement Of BVA-100 Blood Volume Analyzer At Austin Nuclear Pharmacy
Mar 07, 2013: Daxor Announces Sale Of BVA-100 Blood Volume Analyzer To Banner Good Samaritan Medical Center
Feb 14, 2013: Reports Of Study Comparing Daxor’s Direct Blood Volume Measurement With Non-invasive Hemoglobin Monitor In Critically Ill Surgical Patients

SECTION 6 – APPENDIX

Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

LIST OF TABLES

Daxor Corporation, Key Facts
Daxor Corporation, Key Employees
Daxor Corporation, Key Employee Biographies
Daxor Corporation, Major Products and Services
Daxor Corporation Number of Pipeline Products by Equipment Type
Daxor Corporation Pipeline Products by Equipment Type
Daxor Corporation Number of Pipeline Products by Development Stage
Daxor Corporation Pipeline Products by Development Stage
Daxor Corporation, History
Daxor Corporation, Subsidiaries
Daxor Corporation, Key Competitors
Daxor Corporation, Ratios based on current share price
Daxor Corporation, Annual Ratios
Daxor Corporation, Interim Ratios
Daxor Corporation, Medical Equipment, Deals By Year, 2008 to YTD 2014
Daxor Corporation, Medical Equipment, Deals By Type, 2008 to YTD 2014
Daxor Corporation, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

LIST OF FIGURES

Daxor Corporation Pipeline Products by Equipment Type
Daxor Corporation Pipeline Products by Development Stage
Daxor Corporation, Performance Chart (2009 - 2013)
Daxor Corporation, Ratio Charts
Daxor Corporation, Medical Equipment, Deals By Year, 2008 to YTD 2014
Daxor Corporation, Medical Equipment, Deals by Type, 2008 to YTD 2014

Ask Your Question

Daxor Corporation (DXR) - Financial and Strategic SWOT Analysis Review
Company name*:
Contact person*:
Phone/fax*:
Email*:
Request invoice
Your enquiry: